HOUSTON, June 4, 2019 /PRNewswire/ -- Soliton, Inc., (NASDAQ: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback